Cargando…
Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes
Locally advanced non-small cell lung cancer (NSCLC) consists of a heterogeneous group, with different pulmonary extension and lymph nodal involvement. Robotic surgery can play a key role in these tumours thanks to its technological features, although open surgery is still considered the gold-standar...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605396/ https://www.ncbi.nlm.nih.gov/pubmed/37887558 http://dx.doi.org/10.3390/curroncol30100658 |
_version_ | 1785127063552786432 |
---|---|
author | Zirafa, Carmelina C. Romano, Gaetano Sicolo, Elisa Bagalà, Elena Manfredini, Beatrice Alì, Greta Castaldi, Andrea Morganti, Riccardo Davini, Federico Fontanini, Gabriella Melfi, Franca |
author_facet | Zirafa, Carmelina C. Romano, Gaetano Sicolo, Elisa Bagalà, Elena Manfredini, Beatrice Alì, Greta Castaldi, Andrea Morganti, Riccardo Davini, Federico Fontanini, Gabriella Melfi, Franca |
author_sort | Zirafa, Carmelina C. |
collection | PubMed |
description | Locally advanced non-small cell lung cancer (NSCLC) consists of a heterogeneous group, with different pulmonary extension and lymph nodal involvement. Robotic surgery can play a key role in these tumours thanks to its technological features, although open surgery is still considered the gold-standard approach. Our study aims to evaluate the surgical and oncological outcomes of locally advanced NSCLC patients who underwent robotic surgery in a high-volume centre. Data from consecutive patients with locally advanced NSCLC who underwent robotic lobectomy were retrospectively analysed and compared with patients treated with open surgery. Clinical characteristics and surgical and oncological information were evaluated. From 2010 to 2020, 131 patients underwent anatomical lung resection for locally advanced NSCLC. A total of 61 patients were treated with robotic surgery (46.6%); the median hospitalization time was 5.9 days (range 2–27) and the postoperative complication rate was 18%. Open surgery was performed in 70 patients (53.4%); the median length of stay was 9 days (range 4–48) and the postoperative complication rate was 22.9%. The median follow-up time was 70 months. The 5-year overall survival was 34% in the robotic group and 31% in the thoracotomy group. Robotic surgery can be considered safe and feasible not only for early stages but also for the treatment of locally advanced NSCLC. |
format | Online Article Text |
id | pubmed-10605396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106053962023-10-28 Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes Zirafa, Carmelina C. Romano, Gaetano Sicolo, Elisa Bagalà, Elena Manfredini, Beatrice Alì, Greta Castaldi, Andrea Morganti, Riccardo Davini, Federico Fontanini, Gabriella Melfi, Franca Curr Oncol Article Locally advanced non-small cell lung cancer (NSCLC) consists of a heterogeneous group, with different pulmonary extension and lymph nodal involvement. Robotic surgery can play a key role in these tumours thanks to its technological features, although open surgery is still considered the gold-standard approach. Our study aims to evaluate the surgical and oncological outcomes of locally advanced NSCLC patients who underwent robotic surgery in a high-volume centre. Data from consecutive patients with locally advanced NSCLC who underwent robotic lobectomy were retrospectively analysed and compared with patients treated with open surgery. Clinical characteristics and surgical and oncological information were evaluated. From 2010 to 2020, 131 patients underwent anatomical lung resection for locally advanced NSCLC. A total of 61 patients were treated with robotic surgery (46.6%); the median hospitalization time was 5.9 days (range 2–27) and the postoperative complication rate was 18%. Open surgery was performed in 70 patients (53.4%); the median length of stay was 9 days (range 4–48) and the postoperative complication rate was 22.9%. The median follow-up time was 70 months. The 5-year overall survival was 34% in the robotic group and 31% in the thoracotomy group. Robotic surgery can be considered safe and feasible not only for early stages but also for the treatment of locally advanced NSCLC. MDPI 2023-10-12 /pmc/articles/PMC10605396/ /pubmed/37887558 http://dx.doi.org/10.3390/curroncol30100658 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zirafa, Carmelina C. Romano, Gaetano Sicolo, Elisa Bagalà, Elena Manfredini, Beatrice Alì, Greta Castaldi, Andrea Morganti, Riccardo Davini, Federico Fontanini, Gabriella Melfi, Franca Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title | Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title_full | Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title_fullStr | Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title_full_unstemmed | Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title_short | Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes |
title_sort | robotic versus open surgery in locally advanced non-small cell lung cancer: evaluation of surgical and oncological outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605396/ https://www.ncbi.nlm.nih.gov/pubmed/37887558 http://dx.doi.org/10.3390/curroncol30100658 |
work_keys_str_mv | AT zirafacarmelinac roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT romanogaetano roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT sicoloelisa roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT bagalaelena roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT manfredinibeatrice roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT aligreta roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT castaldiandrea roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT morgantiriccardo roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT davinifederico roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT fontaninigabriella roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes AT melfifranca roboticversusopensurgeryinlocallyadvancednonsmallcelllungcancerevaluationofsurgicalandoncologicaloutcomes |